CA2277377C - Controlled release composition - Google Patents

Controlled release composition Download PDF

Info

Publication number
CA2277377C
CA2277377C CA002277377A CA2277377A CA2277377C CA 2277377 C CA2277377 C CA 2277377C CA 002277377 A CA002277377 A CA 002277377A CA 2277377 A CA2277377 A CA 2277377A CA 2277377 C CA2277377 C CA 2277377C
Authority
CA
Canada
Prior art keywords
composition according
diglycerol
composition
active material
biologically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002277377A
Other languages
English (en)
French (fr)
Other versions
CA2277377A1 (en
Inventor
Kare Larsson
Helena Ljusberg-Wahren
Niels Krog
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandberg Development AB
Original Assignee
GS Development AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GS Development AB filed Critical GS Development AB
Publication of CA2277377A1 publication Critical patent/CA2277377A1/en
Application granted granted Critical
Publication of CA2277377C publication Critical patent/CA2277377C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002277377A 1997-01-13 1998-01-08 Controlled release composition Expired - Fee Related CA2277377C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9700061-6 1997-01-13
SE9700061A SE511313C2 (sv) 1997-01-13 1997-01-13 Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol
PCT/SE1998/000009 WO1998030206A1 (en) 1997-01-13 1998-01-08 Controlled release composition

Publications (2)

Publication Number Publication Date
CA2277377A1 CA2277377A1 (en) 1998-07-16
CA2277377C true CA2277377C (en) 2007-12-18

Family

ID=20405393

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002277377A Expired - Fee Related CA2277377C (en) 1997-01-13 1998-01-08 Controlled release composition

Country Status (9)

Country Link
US (1) US6660278B1 (OSRAM)
EP (1) EP0954287B1 (OSRAM)
JP (1) JP2001508773A (OSRAM)
AT (1) ATE243024T1 (OSRAM)
AU (1) AU5583298A (OSRAM)
CA (1) CA2277377C (OSRAM)
DE (1) DE69815659T2 (OSRAM)
SE (1) SE511313C2 (OSRAM)
WO (1) WO1998030206A1 (OSRAM)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020153508A1 (en) 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
BRPI0213425B8 (pt) * 2001-10-19 2021-05-25 Idexx Lab Inc composições injetáveis para a liberação controlada de composto farmacologicamente ativo, usos do referido composto e método para suas preparações
US6946137B2 (en) * 2001-10-19 2005-09-20 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
US7439268B2 (en) * 2003-07-18 2008-10-21 Idexx Laboratories Compositions containing prodrugs of florfenicol and methods of use
US20050049210A1 (en) * 2003-08-27 2005-03-03 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
EP1768650B1 (en) * 2004-06-04 2008-07-16 Camurus Ab Liquid depot formulations
WO2007011385A2 (en) 2004-09-28 2007-01-25 Atrium Medical Corporation Heat cured gel and method of making
WO2006037049A2 (en) 2004-09-28 2006-04-06 Atrium Medical Corporation Application of a coating on a medical device
US9592324B2 (en) 2006-11-06 2017-03-14 Atrium Medical Corporation Tissue separating device with reinforced support for anchoring mechanisms
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US8124127B2 (en) 2005-10-15 2012-02-28 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof
US8288348B2 (en) * 2005-07-13 2012-10-16 Allergan, Inc. Cyclosporin compositions
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
US7550625B2 (en) * 2007-10-19 2009-06-23 Idexx Laboratories Esters of florfenicol
WO2010063080A1 (en) 2008-12-05 2010-06-10 Commonwealth Scientific And Industrial Research Organisation Amphiphile prodrugs
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
WO2011050388A1 (en) * 2009-10-30 2011-05-05 Monash University Liquid crystal composition and method of use
WO2011145659A1 (ja) * 2010-05-18 2011-11-24 富士フイルム株式会社 カロチノイド含有組成物及びその製造方法
EP2593141B1 (en) 2010-07-16 2018-07-04 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
AU2013294915C1 (en) 2012-07-26 2019-11-21 Camurus Ab Opioid formulations
PT2877155T (pt) 2012-07-26 2020-12-18 Camurus Ab Formulações de opioides
CN111432805B (zh) 2017-11-27 2023-02-17 梅克里内科尼蒂翁公司 3α-乙炔基-3β-羟基雄甾烷-17-酮肟的药物制剂
AU2019258590B2 (en) 2018-04-26 2022-09-08 NanoMed Holdings Pty Ltd Gemcitabine amphiphile prodrugs
US12194014B2 (en) 2018-06-21 2025-01-14 NanoMed Holdings Pty Ltd Platinum-based amphiphile prodrugs
EP4284182A1 (de) * 2021-01-29 2023-12-06 IOI Oleo GmbH Polyglycerolfettsäureesterhaltige zusammensetzung

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5321393B2 (OSRAM) * 1974-10-19 1978-07-03
US5264460A (en) * 1988-05-30 1993-11-23 Deutsche Solvay-Werke Gmbh Process for preparing nonionic surfactants
KR0148748B1 (ko) 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
IE65045B1 (en) * 1990-04-28 1995-10-04 Takeda Chemical Industries Ltd Granulated preparations and method of producing the same
WO1992018147A1 (en) 1991-04-19 1992-10-29 Affinity Biotech, Inc. Convertible microemulsion formulations
SE518578C2 (sv) * 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
US6013269A (en) * 1994-10-12 2000-01-11 The Procter & Gamble Company Cosmetic make-up compositions
SE504582C2 (sv) 1995-07-06 1997-03-10 Gs Dev Ab Cyklosporinkomposition baserad på en L2-fas
CZ288739B6 (cs) * 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky

Also Published As

Publication number Publication date
DE69815659T2 (de) 2004-04-29
SE9700061D0 (sv) 1997-01-13
ATE243024T1 (de) 2003-07-15
DE69815659D1 (de) 2003-07-24
AU5583298A (en) 1998-08-03
EP0954287A1 (en) 1999-11-10
JP2001508773A (ja) 2001-07-03
EP0954287B1 (en) 2003-06-18
WO1998030206A1 (en) 1998-07-16
SE511313C2 (sv) 1999-09-06
CA2277377A1 (en) 1998-07-16
US6660278B1 (en) 2003-12-09
SE9700061L (sv) 1998-07-14

Similar Documents

Publication Publication Date Title
EP0954287B1 (en) Controlled release composition
Constantinides Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects
CA2182576C (en) Bilayer preparations
AU691250B2 (en) Lipophilic carrier preparations
US4379755A (en) Gelatinizing agent composition, and gel and aqueous emulsion prepared therefrom
US5589455A (en) Cyclosporin-containing soft capsule compositions
US9522377B2 (en) Method for improving the properties of amphiphile particles
US5603951A (en) Cyclosporin-containing soft capsule compositions
AU763945B2 (en) Oil-core compositions for the sustained release of hydrophobic drugs
MXPA01009817A (es) Composiciones farmaceuticas orales las cuales contienen trigliceridos de cadena larga y tensioactivos lipofilicos.
ZA200209520B (en) Sustained release pharmaceutical compositions for parenteral administration of hydrophilic compounds.
NO844144L (no) Legemiddeltilberedning
WO1988000059A1 (en) A controlled-release composition for a biologically active material dissolved or dispersed in an l2-phase
JPH11508592A (ja) シクロスポリンからなる生物活性組成物
JP6148416B2 (ja) コアシェル構造体及び外用剤
JPS58121209A (ja) 乳化型外用組成物
PL201177B1 (pl) Jadalna mikroemulsja woda w oleju, sposób jej wytwarzania oraz jej zastosowanie
US6235312B1 (en) Liquid crystalline phase drug delivery vehicle
EP1670436B1 (en) Composition comprising ether lipid
US20040213837A1 (en) Oil-core compositions for the sustained release of hydrophobic drugs
JP2016117681A (ja) コアシェル構造体を含有する製剤
BRPI0720489A2 (pt) Cápsulas de gelatina compreendendo um ácido
JPS60192546A (ja) 可食性液状配合油
TW202612685A (zh) 包含唑化合物之組合物
JP2017014129A (ja) 持続性全身作用型外用剤

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20130108